Year-End Report — THE MCMANUS GROUP for ALLERGAN INC (2007)

Firm

THE MCMANUS GROUP

Client

ALLERGAN INC

Income

$60,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2900/S. 1082, Prescription Drug User Fee Act reauthorization H.R. 1038, "Access to Life-Saving Medicine Act" S. 1695, "Biologics Price Competition and Innovation Act of 2007" Public health and issues related to regulation of select agents

Lobbyist	Covered position, as disclosed
JOHN MCMANUS	N/A

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1082 (110th), H.R. 2900 (110th), H.R. 1038 (110th), S. 1695 (110th)

Medicare/Medicaid MMM

Clarification of scope of Medicaid rebates for physician-administered drugs

Lobbyist	Covered position, as disclosed
JOHN MCMANUS	N/A

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.